The present free trade agreement being negotiated between the European Union and India represents a lack of corporate social responsibility and huge concessions by the Government of India, says Stephen Lewis, Order of Canada recipient, former UN special envoy for HIV/AIDS in Africa, and current Visiting Professor at Ryerson University in Toronto.

At present he says, Indian generic pharmaceutical companies provide 80% of all AIDS drugs in the developing world, keeping prices low enough to combat the AIDS pandemic. For the promises of increased trade, and due to the pressure of the pharmaceutical industry on the EU, affordable generic drugs will be difficult to come by, and the priorities of global public health and our human collective right to health will be further eroded.

Read more of Stephen Lewis’ remarks made at the Dean’s Signature Series, Ted Rogers School of Management, Ryerson University, Toronto.

Advertisements